NEW YORK - British drugmaker AstraZeneca PLC yesterday outlined plans to jump-start its widely criticized pipeline by folding in acquired drugs and targeting biologics, in step with an emerging industry-wide trend.
From: www.telegram.com
AstraZeneca plans several new drugs
Posted by Ruslan Abuzant at 2:20 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment